Aisling Capital Management LP 13F Holdings

CIK 0001766721 · NEW YORK, NY

As of Sep 30, 2025, Aisling Capital Management LP reported 14 positions worth $456.4M in its SEC Form 13F filing.

Top 14 holdings

SecurityTickerSectorSharesValue% of portfolio
BRIDGEBIO PHARMA INCBBIOHealthcare6,089,611$316.3M69.29%
VERONA PHARMA PLCVRNAHealthcare615,352$65.7M14.39%
SYNDAX PHARMACEUTICALS INCSNDXHealthcare1,316,806$20.3M4.44%
NUVATION BIO INCNUVBHealthcare2,960,659 1.0M2.40%
MONTE ROSA THERAPEUTICS INCGLUEHealthcare1,472,331 0.9M2.39%
BICARA THERAPEUTICS INCBCAXHealthcare568,919$9.0M1.97%
COMPASS PATHWAYS PLCCMPSHealthcare1,198,418$6.9M1.50%
BRIDGEBIO ONCOLOGY THERAPEUTICS ORDBBOTHealthcare564,625$6.5M1.43%
BIOMEA FUSION INCBMEAHealthcare2,048,757$4.1M0.91%
SCHOLAR ROCK HOLDING CORPSRRKHealthcare77,031$2.9M0.63%
CALCIMEDICA INC——521,114 .6M0.35%
ACLARIS THERAPEUTICS INCACRSHealthcare434,455$825.5K0.18%
MARKER THERAPEUTICS INCMRKRHealthcare325,370$290.4K0.06%
ONKURE THERAPEUTICS INCOKURHealthcare88,607$243.7K0.05%